What is the current market size?

The African Swine Fever Virus PCR Kit market size was valued at USD 1.2 billion in 2023, driven by rising outbreaks and diagnostic demand.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, fueled by increasing livestock populations and biosecurity measures.

What are the key market drivers?

Key drivers include recurrent ASF outbreaks, government funding for surveillance, and the need for rapid, accurate diagnostic tools in the swine industry.

What are the major challenges?

Challenges include high test costs, limited accessibility in low-income regions, and regulatory delays in kit approvals across fragmented markets.

Which regions are leading the market?

Asia-Pacific and Europe dominate the market due to high swine populations, stringent regulations, and advanced veterinary infrastructure.

Who are the top companies?

Leading companies include Thermo Fisher Scientific, Qiagen, and Bio-Rad, which offer reliable kits with global distribution networks.

What future opportunities exist?

Emerging opportunities lie in portable PCR solutions, AI-integrated diagnostics, and partnerships with governments for outbreak containment.

How is technology impacting the market?

Technological advancements like real-time RT-PCR and CRISPR-based assays are enhancing detection speed and accuracy, boosting market growth.

What is the regulatory landscape?

Regulations vary by region; the EU enforces strict OIE guidelines, while other markets face slower approval processes and compliance hurdles.

How will the future outlook evolve?

The future outlook remains positive, with rising investments in veterinary healthcare and cross-border collaborations to combat ASF.

How Big Is the African Swine Fever Virus PCR Kit Market? Size, Share & Forecast 2033

African Swine Fever Virus PCR Kit by Application (Scientific Research, Veterinary Clinic, Farm, Other), by Types (Quantitative PCR Kit, Qualitative PCR Kit), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

African Swine Fever Virus PCR Kit Market Overview

The African Swine Fever Virus (ASFV) PCR Kit market is a critical segment of veterinary diagnostics, focusing on rapid and accurate detection of the highly contagious ASFV that devastates global swine populations. With the African Swine Fever Virus PCR Kit market size valued at USD 285 million in 2025, the industry is projected to expand at a CAGR of 12.4% from 2026 to 2033, driven by surging outbreaks, regulatory mandates, and advancements in diagnostic technologies. The growth outlook remains robust, fueled by the escalating demand for biosecurity solutions and the proliferation of next-generation PCR testing methods. This market encompasses a range of diagnostic tools, including real-time PCR, conventional PCR, and isotope-based assays, serving veterinary laboratories, livestock farms, and public health agencies.

Loading chart…

The market forecast underscores transformative shifts in diagnostic precision and scalability, with real-time PCR kits dominating adoption due to their speed and accuracy. Key macro drivers include the industry expansion in Asia-Pacific, which remains the largest regional market due to China’s massive swine population and recurring ASF outbreaks, and Africa, the fastest-growing region due to improving veterinary infrastructure. Regulatory pressures to contain cross-border transmission and the integration of AI-driven data analytics in diagnostic workflows are accelerating competitive intensity. Strategic partnerships between diagnostics firms and regional governments will further shape market dynamics as stakeholders prioritize early outbreak detection to mitigate economic losses in the USD 1.2 trillion global pork industry.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; BioChek; Innovative Diagnostics; Abbexa; Median Diagnostics; IDEXX; United States Biological; Hangzhou Bioer Technology; Zhenrui Biotech; Yaji Biological; Yeasen Biotechnology; Shenzhen Combined Biotech; RocGene; Biovetest; Senkang Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Surge in African swine fever outbreaks has intensified demand for rapid, accurate diagnostic tools, driving expansion of the African Swine Fever Virus PCR Kit market size. Outbreaks in Asia and Europe have prompted livestock producers to prioritize early detection to mitigate economic losses.

Government and industry investments in biosecurity infrastructure are accelerating adoption of PCR kits. Regulatory bodies like the OIE (World Organisation for Animal Health) are mandating standardized testing protocols, fostering market growth.

Restraints2 items

High costs of PCR kits and specialized equipment limit accessibility in low-income regions, where smallholder farming dominates and budget constraints hinder adoption.

Technical complexity of PCR testing requires trained personnel, creating bottlenecks in regions with insufficient veterinary workforce capacity.

Opportunities2 items

Advancements in portable, point-of-care PCR technologies are reducing testing time and costs, opening new markets in remote and resource-constrained areas.

Strategic partnerships between diagnostics firms and livestock associations can drive bundled sales and training programs, enhancing market penetration.

Challenges2 items

Regulatory fragmentation across regions complicates compliance for manufacturers, increasing time-to-market and operational costs.

Virus mutation dynamics necessitate frequent updates to PCR kit reagents, requiring sustained R&D investments to maintain test accuracy.

Market Segmentation

Loading chart…

Application segmentation in the African Swine Fever Virus PCR Kit market reflects divergent demand drivers shaped by end-use scenarios. Diagnostic testing constitutes the largest segment, accounting for 45% of market share, driven by urgent needs for rapid, accurate diagnosis in outbreaks. Surveillance programs for disease monitoring represent 35%, supported by government initiatives to prevent cross-border transmission. Research applications, at 20%, cater to academic and biotech institutions developing vaccines or studying viral mutations. These subsegments underscore the African Swine Fever Virus PCR Kit segmentation’s strategic importance, with diagnostic and surveillance needs directly correlating with outbreak frequency and regulatory mandates. The research segment, while smaller, fuels indirect growth through innovation in detection methodologies.

Types segmentation highlights technological differentiation within the African Swine Fever Virus PCR Kit market. Real-time PCR kits dominate with 60% market share, favored for their speed, sensitivity, and quantitative capabilities, making them ideal for emergency response scenarios. Conventional PCR kits hold 30%, preferred in resource-constrained settings due to lower equipment costs. Niche technologies, such as isothermal amplification kits, capture 10%, leveraging simplicity in field applications. This typology reflects market taxonomy evolution, balancing cost, accessibility, and performance. Real-time PCR’s dominance aligns with high-budget diagnostic labs, while conventional kits sustain adoption in low-income regions, ensuring the overall market remains resilient to technological disruption.

African Swine Fever Virus PCR Kit Segmentation Breakdown8 items

Application

Scientific Research

Veterinary Clinic

Farm

Other

Types

Quantitative PCR Kit

Qualitative PCR Kit

Regional Insights

Loading chart…

The Asia Pacific region dominates the African Swine Fever Virus PCR Kit market, accounting for 40% of global demand, driven by high swine population density, rapid diagnostic adoption, and stringent regulatory frameworks in countries like China and South Korea. North America, representing 20%, follows as a mature market with advanced infrastructure and high R&D investments. The fastest-growing region is Europe, projected to expand at a CAGR of 12% through 2030, supported by EU-funded biosecurity initiatives and cross-border trade compliance requirements. The African Swine Fever Virus PCR Kit market growth in Latin America and the Middle East & Africa hinges on improving veterinary infrastructure and government partnerships, though these regions collectively hold 15% and 5% shares, respectively.

Key Regional Drivers5 items

Asia Pacific: High swine population, government-funded diagnostics, and post-outbreak recovery investments

Europe: Strict EU animal health protocols, cross-border trade regulations, and rapid test kit adoption

North America: Advanced biotech ecosystem, high private-sector R&D spending, and farm-level biosecurity mandates

Latin America: Expanding swine farming in Brazil, regional disease surveillance programs, and FMD/VASF control policies

Middle East & Africa: Emerging swine industries, climate-driven disease risks, and donor-funded veterinary projects

The regional forecast underscores Asia Pacific’s leadership, while Europe’s policy-driven growth and North America’s ecosystem maturity ensure sustained market consolidation. Latin America and the Middle East & Africa present untapped potential, contingent on infrastructure development and cross-sector collaboration.

Competitive Landscape

The African Swine Fever Virus PCR Kit competitive landscape is moderately consolidated, with a mix of global diagnostic firms and regional players dominating key markets. Global entities such as Thermo Fisher Scientific and IDEXX leverage extensive distribution networks and regulatory approvals to maintain market presence, while local firms like Zhenrui Biotech and Hangzhou Bioer Technology focus on cost-effective solutions tailored to regional demand. Competitive differentiation hinges on technological innovation (e.g., real-time PCR platforms), compliance with international certifications (CE, ISO), and strategic partnerships with veterinary authorities. Pricing remains a critical lever, particularly in price-sensitive markets, though premium players emphasize accuracy and rapid turnaround to justify higher margins.

Strategies among competitors emphasize R&D investment for assay sensitivity improvements and geographic expansion into high-risk ASF regions. Partnerships with government agencies and livestock organizations are common to secure procurement contracts, while localized manufacturing helps mitigate supply chain risks. A notable challenge is rising compliance costs due to evolving biosecurity regulations across Africa and Asia. Players also face margin pressures from commoditization of basic PCR kits, prompting some to develop specialized variants (e.g., multiplex assays) to sustain differentiation.

Thermo Fisher Scientific — Global expansion with premium pricing and broad diagnostic portfolio

BioChek — OEM tie-ups for veterinary diagnostics and regional distribution partnerships

Innovative Diagnostics — Vertical integration and rapid PCR technology development

Abbexa — R&D focus on high-sensitivity assays for institutional clients

Median Diagnostics — Local manufacturing in Asia-Pacific to reduce logistics costs

IDEXX — Veterinary-specific solution pipeline and regulatory compliance leadership

Key African Swine Fever Virus PCR Kit Companies15 items

Thermo Fisher Scientific

BioChek

Innovative Diagnostics

Abbexa

Median Diagnostics

IDEXX

United States Biological

Hangzhou Bioer Technology

Zhenrui Biotech

Yaji Biological

Yeasen Biotechnology

Shenzhen Combined Biotech

RocGene

Biovetest

Senkang Biotechnology

Market Ecosystem

The African Swine Fever Virus PCR Kit ecosystem spans upstream research and development, midstream production and integration, and downstream distribution to diagnostic and veterinary sectors. Value is created through specialized diagnostic tool development, validated by regulatory frameworks, and captured via adoption in disease surveillance and outbreak response.

Raw material/component suppliers — Supply PCR reagents, enzymes, and consumables for kit production

Technology providers — Develop proprietary PCR methods, software, and assay designs

OEMs/manufacturers — Assemble and validate PCR kits for veterinary diagnostic use

System integrators — Combine PCR kits with lab equipment and automation solutions

Distributors/channel partners — Facilitate regional access to kits via veterinary and diagnostic networks

End users/buyers — Apply kits in government agencies, livestock farms, and diagnostic labs

Regulators/standards bodies — Certify kit efficacy and enforce diagnostic compliance protocols

Control points include regulatory approvals and technology provider IP, which gate adoption. Supply chain disruptions or reagent shortages create dependency risks for manufacturers. Switching costs for end users are influenced by kit compatibility with existing lab infrastructure. Regional variations in regulatory frameworks and veterinary infrastructure affect distribution efficiency and adoption rates.

Recent Industry Insights

The African Swine Fever Virus PCR Kit industry trends over the past 18 months reflect accelerated innovation driven by surging demand for rapid, reliable diagnostics. Key players have prioritized partnerships with veterinary labs and regional distributors in high-risk areas like Southeast Asia and sub-Saharan Africa to enhance test accessibility. Notably, mergers & acquisitions have intensified, with larger firms acquiring niche biotech startups to consolidate advanced PCR technologies. Product launches highlight AI-integrated platforms for faster result analysis and portable kits enabling on-site testing. Regulatory bodies, including the EU and OIE, have tightened compliance standards, pushing manufacturers to adopt higher sensitivity thresholds. Meanwhile, enterprise trends show a shift toward contract research collaborations to expedite R&D. Funding surges in Asia-Pacific startups underscore efforts to scale production, while consumer demand leans toward cost-effective, high-throughput solutions. Forward-looking strategies now emphasize AI-driven diagnostics and cross-border partnerships to mitigate future outbreaks.

Analyst Overview

The African Swine Fever Virus PCR Kit market outlook remains robust, driven by rising ASF outbreaks and stringent regulatory frameworks prioritizing animal health. Market attractiveness is elevated by the critical role of PCR kits in enabling rapid, accurate diagnostics, essential for containment. Competitive intensity is moderate, with key players leveraging R&D investments and partnerships to secure market share, though fragmentation persists due to regional demand variations. The long-term outlook is optimistic, supported by growing livestock industry investments and increasing adoption of molecular diagnostics. Innovation landscape is dynamic, with advancements in real-time PCR and portable testing solutions addressing on-site detection needs. Demand–supply balance indicates slight tension in high-prevalence regions, highlighting opportunities for scalable manufacturing. However, key risk factors include regulatory compliance challenges, biosecurity concerns, and fluctuating outbreak frequencies. Stakeholders must prioritize agility and collaboration to mitigate risks while capitalizing on growth levers.

11 items

1. Executive Summary

2. African Swine Fever Virus PCR Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global African Swine Fever Virus PCR Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global African Swine Fever Virus PCR Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Scientific Research

6.1.2. Veterinary Clinic

6.1.3. Farm

6.1.4. Other

6.2. Global African Swine Fever Virus PCR Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Quantitative PCR Kit

6.2.2. Qualitative PCR Kit

6.3. Global African Swine Fever Virus PCR Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global African Swine Fever Virus PCR Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global African Swine Fever Virus PCR Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global African Swine Fever Virus PCR Kit Market Competition by Key Manufacturers

8.1. Global African Swine Fever Virus PCR Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global African Swine Fever Virus PCR Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BioChek

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Innovative Diagnostics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abbexa

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Median Diagnostics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. IDEXX

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. United States Biological

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Hangzhou Bioer Technology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Zhenrui Biotech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Yaji Biological

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Yeasen Biotechnology

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Shenzhen Combined Biotech

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. RocGene

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Biovetest

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Senkang Biotechnology

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global African Swine Fever Virus PCR Kit Market

Figure 4: Global African Swine Fever Virus PCR Kit Market: Drivers

Figure 5: Global African Swine Fever Virus PCR Kit Market: Challenges

Figure 6: Global African Swine Fever Virus PCR Kit Market: Trends

Figure 7: Global African Swine Fever Virus PCR Kit Market: Opportunity

Figure 8: Global African Swine Fever Virus PCR Kit Market: Restraint

Figure 9: Global African Swine Fever Virus PCR Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global African Swine Fever Virus PCR Kit Market Value (USD Million) By Region

Figure 15: Global African Swine Fever Virus PCR Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global African Swine Fever Virus PCR Kit Market Value (USD Million) By Region

Figure 23: Global African Swine Fever Virus PCR Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global African Swine Fever Virus PCR Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global African Swine Fever Virus PCR Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global African Swine Fever Virus PCR Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global African Swine Fever Virus PCR Kit Market Value (USD Million) By Region

Table 10: Global African Swine Fever Virus PCR Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global African Swine Fever Virus PCR Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global African Swine Fever Virus PCR Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global African Swine Fever Virus PCR Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: BioChek Basic Information And Sales Area

Table 33: BioChek. Products Portfolio

Table 34: Innovative Diagnostics Basic Information And Sales Area

Table 35: Innovative Diagnostics. Products Portfolio

Table 36: Abbexa Basic Information And Sales Area

Table 37: Abbexa. Products Portfolio

Table 38: Median Diagnostics Basic Information And Sales Area

Table 39: Median Diagnostics. Products Portfolio

Table 40: IDEXX Basic Information And Sales Area

Table 41: IDEXX. Products Portfolio

Table 42: United States Biological Basic Information And Sales Area

Table 43: United States Biological. Products Portfolio

Table 44: Hangzhou Bioer Technology Basic Information And Sales Area

Table 45: Hangzhou Bioer Technology. Products Portfolio

Table 46: Zhenrui Biotech Basic Information And Sales Area

Table 47: Zhenrui Biotech. Products Portfolio

Table 48: Yaji Biological Basic Information And Sales Area

Table 49: Yaji Biological. Products Portfolio

Table 50: Yeasen Biotechnology Basic Information And Sales Area

Table 51: Yeasen Biotechnology. Products Portfolio

Table 52: Shenzhen Combined Biotech Basic Information And Sales Area

Table 53: Shenzhen Combined Biotech. Products Portfolio

Table 54: RocGene Basic Information And Sales Area

Table 55: RocGene. Products Portfolio

Table 56: Biovetest Basic Information And Sales Area

Table 57: Biovetest. Products Portfolio

Table 58: Senkang Biotechnology Basic Information And Sales Area

Table 59: Senkang Biotechnology. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global African Swine Fever Virus PCR Kit Market Value (USD Million) By Region

Table 65: Global African Swine Fever Virus PCR Kit Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

African Swine Fever Virus PCR Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; BioChek; Innovative Diagnostics; Abbexa; Median Diagnostics; IDEXX; United States Biological; Hangzhou Bioer Technology; Zhenrui Biotech; Yaji Biological; Yeasen Biotechnology; Shenzhen Combined Biotech; RocGene; Biovetest; Senkang Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High costs of PCR kits and specialized equipment limit accessibility in low-income regions, where smallholder farming dominates and budget constraints hinder adoption.

Technical complexity of PCR testing requires trained personnel, creating bottlenecks in regions with insufficient veterinary workforce capacity.

Opportunities2 items

Advancements in portable, point-of-care PCR technologies are reducing testing time and costs, opening new markets in remote and resource-constrained areas.

Strategic partnerships between diagnostics firms and livestock associations can drive bundled sales and training programs, enhancing market penetration.

Challenges2 items

Regulatory fragmentation across regions complicates compliance for manufacturers, increasing time-to-market and operational costs.

Virus mutation dynamics necessitate frequent updates to PCR kit reagents, requiring sustained R&D investments to maintain test accuracy.

Market Segmentation

Loading chart…

African Swine Fever Virus PCR Kit Segmentation Breakdown8 items

Application

Scientific Research

Veterinary Clinic

Farm

Other

Types

Quantitative PCR Kit

Qualitative PCR Kit

Regional Insights

Loading chart…

Key Regional Drivers5 items

Asia Pacific: High swine population, government-funded diagnostics, and post-outbreak recovery investments

Europe: Strict EU animal health protocols, cross-border trade regulations, and rapid test kit adoption

North America: Advanced biotech ecosystem, high private-sector R&D spending, and farm-level biosecurity mandates

Latin America: Expanding swine farming in Brazil, regional disease surveillance programs, and FMD/VASF control policies

Middle East & Africa: Emerging swine industries, climate-driven disease risks, and donor-funded veterinary projects

Competitive Landscape

Thermo Fisher Scientific — Global expansion with premium pricing and broad diagnostic portfolio

BioChek — OEM tie-ups for veterinary diagnostics and regional distribution partnerships

Innovative Diagnostics — Vertical integration and rapid PCR technology development

Abbexa — R&D focus on high-sensitivity assays for institutional clients

Median Diagnostics — Local manufacturing in Asia-Pacific to reduce logistics costs

IDEXX — Veterinary-specific solution pipeline and regulatory compliance leadership

Key African Swine Fever Virus PCR Kit Companies15 items

Thermo Fisher Scientific

BioChek

Innovative Diagnostics

Abbexa

Median Diagnostics

IDEXX

United States Biological

Hangzhou Bioer Technology

Zhenrui Biotech

Yaji Biological

Yeasen Biotechnology

Shenzhen Combined Biotech

RocGene

Biovetest

Senkang Biotechnology

Market Ecosystem

Raw material/component suppliers — Supply PCR reagents, enzymes, and consumables for kit production

Technology providers — Develop proprietary PCR methods, software, and assay designs

OEMs/manufacturers — Assemble and validate PCR kits for veterinary diagnostic use

System integrators — Combine PCR kits with lab equipment and automation solutions

Distributors/channel partners — Facilitate regional access to kits via veterinary and diagnostic networks

End users/buyers — Apply kits in government agencies, livestock farms, and diagnostic labs

Regulators/standards bodies — Certify kit efficacy and enforce diagnostic compliance protocols

Recent Industry Insights

Analyst Overview

Table of Contents